US HB4629 | 2019-2020 | 116th Congress

Status

Spectrum: Bipartisan Bill
Status: Introduced on October 8 2019 - 25% progression
Action: 2019-10-08 - Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Star Rating for Biosimilars Act

Tracking Information

Register now for our free OneVote public service or GAITS Professional trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Star Rating for Biosimilars Act

Sponsors


History

DateChamberAction
2019-10-08HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-10-08HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-10-08HouseIntroduced in House

Same As/Similar To

SB2543 (Related) 2019-09-25 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 225.

Subjects


US Congress State Sources


Bill Comments

feedback